company background image
EVFM logo

Evofem Biosciences OTCPK:EVFM Stock Report

Last Price

US$0.026

Market Cap

US$1.2m

7D

64.6%

1Y

-99.1%

Updated

27 Mar, 2024

Data

Company Financials

Evofem Biosciences, Inc.

OTCPK:EVFM Stock Report

Market Cap: US$1.2m

EVFM Stock Overview

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health.

EVFM fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance2/6
Financial Health0/6
Dividends0/6

Evofem Biosciences, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Evofem Biosciences
Historical stock prices
Current Share PriceUS$0.026
52 Week HighUS$4.38
52 Week LowUS$0.012
Beta-1.2
1 Month Change23.22%
3 Month Change-62.32%
1 Year Change-99.05%
3 Year Change-100.00%
5 Year Change-100.00%
Change since IPO-100.00%

Recent News & Updates

Recent updates

Evofem partners with a360 Media to support Phexxi prescription growth

Jul 21

Evofem announces peer-reviewed publication on birth control method

Jul 12

Female Contraception Post Roe V. Wade - Evofem CEO Saundra Pelletier

Jul 06

Evofem announces U.S. patent win for birth control method

Jun 30

Evofem: ACA Coverage Of Phexxi Is A Game Changer

Jan 18

Shareholder Returns

EVFMUS PharmaceuticalsUS Market
7D64.6%-0.2%0.6%
1Y-99.1%23.9%29.5%

Return vs Industry: EVFM underperformed the US Pharmaceuticals industry which returned 23.9% over the past year.

Return vs Market: EVFM underperformed the US Market which returned 29.5% over the past year.

Price Volatility

Is EVFM's price volatile compared to industry and market?
EVFM volatility
EVFM Average Weekly Movement36.4%
Pharmaceuticals Industry Average Movement9.5%
Market Average Movement6.0%
10% most volatile stocks in US Market16.9%
10% least volatile stocks in US Market3.0%

Stable Share Price: EVFM's share price has been volatile over the past 3 months.

Volatility Over Time: EVFM's weekly volatility has increased from 27% to 36% over the past year.

About the Company

FoundedEmployeesCEOWebsite
n/a36Saundra Pelletierhttps://www.evofem.com

Evofem Biosciences, Inc., a biopharmaceutical company, develops and commercializes various products to address unmet needs in women’s sexual and reproductive health. Its commercial product is Phexxi, a vaginal gel for the prevention of pregnancy. The company is also involved in the development of EVO100 for the prevention of chlamydia and gonorrhea in Women; and EVO200 for the prevention of recurrent bacterial vaginosis.

Evofem Biosciences, Inc. Fundamentals Summary

How do Evofem Biosciences's earnings and revenue compare to its market cap?
EVFM fundamental statistics
Market capUS$1.22m
Earnings (TTM)US$55.96m
Revenue (TTM)US$18.22m

0.0x

P/E Ratio

0.1x

P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
EVFM income statement (TTM)
RevenueUS$18.22m
Cost of RevenueUS$6.51m
Gross ProfitUS$11.71m
Other Expenses-US$44.26m
EarningsUS$55.96m

Last Reported Earnings

Dec 31, 2023

Next Earnings Date

n/a

Earnings per share (EPS)1.19
Gross Margin64.26%
Net Profit Margin307.19%
Debt/Equity Ratio-69.9%

How did EVFM perform over the long term?

See historical performance and comparison
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.